Tag Archive for Q4

Nature’s Sunshine Products Reports Fourth Quarter Net Sales Up 5.2% To $88.3 Million

Nature’s Sunshine Products, Inc. (Nasdaq:NATR), a leading natural health and wellness company engaged in the manufacture and direct selling of nutritional and personal care products, today reported its financial results for the fourth quarter ended December 31, 2017.
At this time, the Company is providing preliminary ranges for its anticipated net loss for the fourth quarter and fiscal 2017 pending final determination of its provision for income taxes, including the impact of U.S. tax reform, among other factors. The Company expects to file its audited financial statements on form 10-K on March 16, 2018.
Management Commentary
“Our fourth quarter results reflect continued year-over-year net sales growth, driven by gains across our Synergy Worldwide markets and strong growth in our NSP business in Russia, Central and Eastern Europe,” commented Gregory L. Probert, Chairman and Chief Executive Officer.
“We believe the disruptions to our North America business as a result of a new ERP system deployed in April 2017 are now behind us, but we have additional work to do to re-energize the market. We posted growth in China and continue to emphasize expanding our direct selling efforts in this market with the goal of building a long-term profitable new market. Consistent with our initiative to

Read more...

Nu Skin Q4 Sales Down 7% To $531 Million

 
Nu Skin Enterprises, Inc. (NYSE: NUS) today announced fourth-quarter results with revenue of $531.3 million, compared to $572.2 million in the prior-year period. Quarterly revenue was negatively impacted 1 percent by foreign currency fluctuations. Earnings per share for the quarter were $0.69, compared to $0.62 in the prior-year period.
The company’s earnings per share in the fourth quarter included a negative $0.10 impact from a tax charge related to the enactment of a new U.S. tax regulation in December.
The company also reported full-year 2016 revenue of $2.21 billion, compared to $2.25 billion in 2015. Annual revenue was approximately even on a local-currency basis but was negatively impacted 2 percent by a strong U.S. dollar. Earnings per share for 2016 were $2.55, compared to $2.25 in 2015.
The company also reiterated guidance provided at its 2016 investor day in December

Read more...

Nu Skin Q4 Revenue Down From $1.06 Billion To $609 Million

 
Nu Skin Enterprises, Inc. (NYSE: NUS) today announced fourth-quarter results with revenue of $609.6 million, the top end of the company’s guidance, compared to $1.06 billion in the prior-year period.
Revenue in the fourth quarter of 2013 was augmented by $350 million in limited-time offer sales of the ageLOC TR90 weight management system. Revenue for the quarter was negatively impacted 4 percent by foreign currency fluctuations.
Earnings per share for the quarter were at the top end of guidance at $0.77, versus $2.02 in the prior-year period. Earnings per share for the quarter were negatively impacted $0.08 by prepayment fees associated with the refinancing of the company’s debt, and $0.06 by foreign currency translation expense.
The company reported full-year 2014 revenue of $2.57 billion, a 19 percent year-over-year decline.  Annual revenue was negatively impacted 3 percent by foreign currency fluctuations. Earnings per share for the year were $3.11 compared to $5.94 in 2013.

“Our business performed as we expected for the quarter, and we look forward to a solid 2015,” said Truman Hunt, president and chief executive officer.

“As we review the year, three factors impacted our results. First, our year-over-year comparisons were especially challenging considering that we were lapping a $550 million

Read more...